Literature DB >> 8740256

Familial central serous retinopathy.

J A Oosterhuis1.   

Abstract

PURPOSE: To study the familial occurrence of central serous retinopathy (CSR).
METHODS: We pooled data from eight eye clinics in Western Europe.
RESULTS: We collected 11 families that each had two to four members with CSR. In 10 families siblings and in one family a mother and son were affected. Sixty percent of the patients were male and 40% female. CSR was found in 55 (92%) of 60 eyes, 44 (80%) showing a chronic course. In 25 patients (83%) both eyes were affected. Most recent visual acuity was 0.5 or less in 17 (39%) and 0.2 or less in 8 (18%) of the eyes with chronic CSR.
CONCLUSION: Our findings of familial occurrence and a chronic disorder that is progressive, diffuse, and bilateral suggest an inborn disposition to develop a clinically manifest disintegration of the retinal pigment epithelium in adulthood.

Entities:  

Mesh:

Year:  1996        PMID: 8740256     DOI: 10.1007/bf00220710

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  21 in total

1.  Photocoagulation treatment of idiopathic central serous choroidopathy.

Authors:  J D Gass
Journal:  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol       Date:  1977 May-Jun

2.  Bullous retinal detachment. An unusual manifestation of idiopathic central serous choroidopathy.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1973-05       Impact factor: 5.258

3.  Type A behavior and central serous chorioretinopathy.

Authors:  L A Yannuzzi
Journal:  Trans Am Ophthalmol Soc       Date:  1986

4.  Retinal pigment epithelium decompensation. II. Laser treatment.

Authors:  A E Jalkh; N Jabbour; M P Avila; C L Trempe; C L Schepens
Journal:  Ophthalmology       Date:  1984-12       Impact factor: 12.079

5.  Long-term follow-up of central serous retinopathy.

Authors:  M Nanjiani
Journal:  Trans Ophthalmol Soc U K       Date:  1977-09

6.  Idiopathic serous detachment of the retinal pigment epithelium.

Authors:  M L Lewis
Journal:  Arch Ophthalmol       Date:  1978-04

7.  ["Trace-like" atrophic epitheliopathy].

Authors:  A Giovannini
Journal:  Bull Mem Soc Fr Ophtalmol       Date:  1982

8.  Central serous chorioretinopathy in endogenous hypercortisolism.

Authors:  E A Bouzas; M H Scott; G Mastorakos; G P Chrousos; M I Kaiser-Kupfer
Journal:  Arch Ophthalmol       Date:  1993-09

9.  [Central serous retinopathy (atypical forms)].

Authors:  R Brancato; F Bandello
Journal:  Bull Soc Belge Ophtalmol       Date:  1991

10.  Central serous chorioretinopathy occurring in patients 60 years of age and older.

Authors:  H Schatz; D Madeira; R N Johnson; H R McDonald
Journal:  Ophthalmology       Date:  1992-01       Impact factor: 12.079

View more
  11 in total

1.  [Central serous chorioretinopathy (CSC)].

Authors:  H Baraki; N Feltgen; J Roider; H Hoerauf; C Klatt
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

Review 2.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

3.  Association of central serous chorioretinopathy with single nucleotide polymorphisms in complement factor H gene in Iranian population.

Authors:  Reza Karkhaneh; Mohsen Toufighi; Akbar Amirfiroozy; Aliasghar Ahmad-Raji; Oveis Ahmadzadeh; Alborz Mahdavi; Morteza Naderan
Journal:  Eye (Lond)       Date:  2021-05-11       Impact factor: 3.775

4.  CFH and VIPR2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy.

Authors:  Yoshikatsu Hosoda; Munemitsu Yoshikawa; Masahiro Miyake; Yasuharu Tabara; Jeeyun Ahn; Se Joon Woo; Shigeru Honda; Yoichi Sakurada; Chieko Shiragami; Hideo Nakanishi; Akio Oishi; Sotaro Ooto; Akiko Miki; Tomohiro Iida; Hiroyuki Iijima; Makoto Nakamura; Chiea Chuen Khor; Tien Yin Wong; Kyuyoung Song; Kyu Hyung Park; Ryo Yamada; Fumihiko Matsuda; Akitaka Tsujikawa; Kenji Yamashiro
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-29       Impact factor: 11.205

5.  Exome sequencing in families with chronic central serous chorioretinopathy.

Authors:  Rosa L Schellevis; Elon H C van Dijk; Myrte B Breukink; Jan E E Keunen; Gijs W E Santen; Carel B Hoyng; Eiko K de Jong; Camiel J F Boon; Anneke I den Hollander
Journal:  Mol Genet Genomic Med       Date:  2019-02-06       Impact factor: 2.183

6.  Increased risk of central serous chorioretinopathy following end-stage renal disease: A nationwide population-based study.

Authors:  Yuh-Shin Chang; Shih-Feng Weng; Jhi-Joung Wang; Ren-Long Jan
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

7.  Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathy.

Authors:  Carl Schubert; Anders Pryds; Shemin Zeng; Yajing Xie; K Bailey Freund; Richard F Spaide; John C Merriam; Irene Barbazetto; Jason S Slakter; Stanley Chang; Inger C Munch; Arlene V Drack; Jasmine Hernandez; Suzanne Yzer; Joanna E Merriam; Allan Linneberg; Michael Larsen; Lawrence A Yannuzzi; Robert F Mullins; Rando Allikmets
Journal:  Hum Mutat       Date:  2014-07       Impact factor: 4.700

8.  Systemic complement activation in central serous chorioretinopathy.

Authors:  Elon H C van Dijk; Roula Tsonaka; Ngaisah Klar-Mohamad; Diana Wouters; Aiko P J de Vries; Eiko K de Jong; Cees van Kooten; Camiel J F Boon
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

9.  Quantitative Assessment of Asymmetric Choroidal Outflow in Pachychoroid Eyes on Ultra-Widefield Indocyanine Green Angiography.

Authors:  Jesse J Jung; Daryle Jason G Yu; Kazuyo Ito; Soraya Rofagha; Scott S Lee; Quan V Hoang
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-07-01       Impact factor: 4.799

10.  Associations of Single-Nucleotide Polymorphisms in Slovenian Patients with Acute Central Serous Chorioretinopathy.

Authors:  Peter Kiraly; Andrej Zupan; Alenka Matjašič; Polona Jaki Mekjavić
Journal:  Genes (Basel)       Date:  2021-12-25       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.